he MFDS decided on the 8th to temporarily suspend the manufacture and sale of six medicines manufactured by BINEX and to collect them. The MFDS is also launching an investigation into a factory located in Busan.

Drugs subject to disposal are Amorin (Glimepiride), Xelectin (Fluoxetine), Daxfen (Dexibuprofen), Rofsin 250 mg (Ciprofloxacin), Xelectin 10 mg (Fluoxetine), Cadil 1 mg (Doxazosin).

This measure was decided by the MFDS as a precautionary measure against BINEX's submission of a recovery plan for the item manufactured differently from the licensed or reported items to the MFDS, Busan Office. The MFDS policy is to conduct an investigation to confirm the overall manufacturing and qu